ATRA
Atara Biotherapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$8.29-1.19%
Price as of Jul 20, 2026
ATRA capital
Atara Biotherapeutics, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- -0.27x
- Net debt / equity
- -0.05x
- Debt / assets
- 0.50x
- Debt / EBITDA
- -1.84x
- Net debt / EBITDA
- -0.32x
Liquidity & coverage
- Current ratio
- 2.16x
- Quick ratio
- 2.16x
- Cash ratio
- 1.48x
- Interest coverage
- -1.75x
- EBITDA / interest
- -1.52x
- Working capital
- $6.5M
Cash & dividend
- FCF / debt
- -2.56x
- Cash flow / debt
- -2.56x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.